Just six months ago, when markets were very volatile because of tariffs and economic uncertainty, our Investors’ Edge column ...

Anna Paglia, State Street chief business officer, and Todd Rosenbluth, VettaFi head of research, sit down with CNBC's Dominic ...

Google and Amazon earn billions from AI startup Anthropic. Both tech giants are reaping massive paper gains. Alphabet ...

Once a formidable economic moat is built and earnings take off, many investors tend to notice. But if a savvy investor can ...

Barron’s Investor Circle is where Barron’s readers become part of a vibrant investing community—and take their stock picking ...

UK universities are a vital economic asset, but they are also Britain's 'equivalent of Gulf oil.' There are opportunities here for investors, says Matthew Partridge ...

CrowdStrike remains a cybersecurity leader with strong fundamentals, but current valuations are stretched and leave little ...

I worry that the U.S. is falling behind China in the quest for AI dominance. And in the quest for quantum superiority. And in ...

Peter Wright advises executives to align with institutional investors by shifting from private market dreams to a measured cadence. The core message must answer: "How do you make money, and how do I ...

In this article, we narrow the list into seven best cryptocurrency trading courses, each offering a unique product and the ...

The Australian Government has introduced the Guarantee of Origin (GO) scheme, a voluntary framework designed to support ...

Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced financial results for the third quarter ended September 30, 2025.